Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

ACR blasts ‘deeply flawed’ Anthem policy targeting out-of-network radiologists
Last month, the insurance giant announced it will begin charging hospitals a 10% administrative penalty for claims that involve docs outside of its networks.
Radiology provider Lumexa Imaging seeks to raise $200M through IPO
If the effort succeeds, the Raleigh, North Carolina-based imaging group would soon begin trading on the Nasdaq under the ticker symbol LMRI.
Colorado law barring medical debt from credit reports faces federal challenge from trade lobby
While the law sunsets in 2028, ACA International and the debt collector Creditors Bureau USA are not waiting. They filed a lawsuit in federal court arguing that Colorado is illegally restricting free speech, in violation of the First Amendment.
$64M raised for new cardiogenic shock drug—research already underway
Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.
Interventional radiologists who neglect E&M visits risk losing more lucrative procedures
“This study affirms that when interventional radiologists are afforded the time to evaluate and follow their patients, the complexity and value of the care they provide increases," one expert notes.

RadNet to acquire California-based Kern Radiology

RadNet announced Monday, Feb. 11, that it has signed a definitive agreement to acquire Kern Radiology Medical Group, a Bakersfield, California-based outpatient radiology practice that owns five imaging centers.

11 policy recommendations for AI’s role in healthcare

Though healthcare organizations have started to realize AI’s potential, a health coalition led by providers, payers and vendors has made 11 policy recommendations for the technology's role in the space.

Cardiovascular line items central to hospitals’ outpatient revenue

Cardiovascular diagnoses such as chest pain and atherosclerotic heart disease are key drivers of outpatient payments, which accounted for almost 57 percent of hospitals’ net patient revenue in 2017, according to data compiled by Definitive Healthcare.

Owkin, Arterys among 14 health companies named as top AI startups

More than a dozen healthcare AI companies—including Owkin and Arterys—have been named as top startups in CB Insight’s third annual AI 100 list.

New report highlights precision medical imaging’s $8B future

The precision medical imaging market is expected to grow from $120 million in 2017 to more than $8 billion in 2027, according to new analysis from Frost & Sullivan.

KenSci CEO on why AI is really 'assistive intelligence'

The rise of AI and machine learning in the healthcare market hasn’t gone unnoticed by KenSci, a Seattle-based company that offers an AI and machine learning platform for healthcare groups. The company has now raised an additional $22 million in hopes of growing along with the market.

Health Catalyst secures $100M to expand machine learning solutions

Utah-based healthcare big data company Health Catalyst announced it has closed $100 million in Series F equity and debt funding. Financing will support the expansion of Health Catalyst’s technology and services offering for healthcare information.

AI health tech company raises $3.1 million

Medicus AI GmbH, a Dubai-based technology company that uses AI to make health data more understandable, has raised about $3.1 million in a Series A funding round, according to information available on Crunchbase.

Economics

ACR blasts ‘deeply flawed’ Anthem policy targeting out-of-network radiologists

Radiology provider Lumexa Imaging seeks to raise $200M through IPO

Colorado law barring medical debt from credit reports faces federal challenge from trade lobby

$64M raised for new cardiogenic shock drug—research already underway

Interventional radiologists who neglect E&M visits risk losing more lucrative procedures